Science Explorer Interactive view Map
Funder · Novara · Italy

Azienda Ospedaliero Universitaria Maggiore della Carita

In research, Azienda Ospedaliero Universitaria Maggiore della Carita stands highest in Health Sciences (#4,448 of 11,982 worldwide) and Medicine (#5,096 of 10,443 worldwide), 2022–2025.

maggioreosp.novara.it/site/home.htmlROR OpenAlex
World rank, 2022–2025
#11,416
of 28,054 · #15,938 all time
Rank in Italy
#321
of 618
Research works
650
▲ 27% vs 2013–17
Citations
12k
18.4 per fractional work
Top-10% rate
18.2%
record average 16.5%
Open access
52%
world 28%

What is Azienda Ospedaliero Universitaria Maggiore della Carita known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #4,448 of 11,982 17.6%143 #5772
MedicineField #5,096 of 10,443 17.2%137 #4960

Each strip is that field’s whole ranked pool, with the notch where Azienda Ospedaliero Universitaria Maggiore della Carita sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.50× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 3.02× its world share, 5 worksImmunology and Micro…Neuroscience: 0.83× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.46× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.19× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 1 worksComputer ScienceEngineering: 0.08× its world share, 2 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 0.10× its world share, 0 worksMathematicsPhysics and Astronomy: 0.23× its world share, 1 worksPhysics and AstronomyDentistry: 1.48× its world share, 1 worksDentistryHealth Professions: 0.85× its world share, 4 worksHealth ProfessionsMedicine: 4.01× its world share, 137 worksMedicineNursing: 0.88× its world share, 1 worksNursingVeterinary: 0.66× its world share, 0 worksVeterinaryArts and Humanities: 0.08× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Decision Sciences: 0.06× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…Psychology: 0.85× its world share, 5 worksPsychologySocial Sciences: 0.05× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Which keywords describe research at Azienda Ospedaliero Universitaria Maggiore della Carita?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Inflammation, Treatment, Immunotherapy, Heart Failure, Cancer and Genetic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology20▲ 2.8×88 topics
  2. Inflammation12▲ 3.2×53 topics
  3. Treatment10▲ 4.5×37 topics
  4. Diagnosis9▲ 5.5×32 topics
  5. Cancer8▲ 3.3×29 topics
  6. Immunotherapy8▲ 6.2×16 topics
  7. Oxidative Stress6▲ 2.2×28 topics
  8. Chemotherapy6▲ 4.7×21 topics
  9. Risk Factors6▲ 3.0×21 topics
  10. Quality of Life6▲ 2.2×30 topics
  11. Genetic Mutations6▲ 7.1×15 topics
  12. Heart Failure6▲ 7.2×13 topics
  13. Management5▲ 3.9×21 topics
  14. Cardiovascular Disease5▲ 2.7×24 topics
  15. Clinical Practice Guidelines5▲ 5.5×13 topics
  16. Echocardiography5▲ 10×7 topics
  17. Prognostic Factors5▲ 6.3×12 topics
  18. Genetics5▲ 3.8×14 topics
  19. Guidelines5▲ 5.6×11 topics
  20. Neurodegeneration5▲ 8.7×10 topics
  21. Radiotherapy4▲ 6.3×12 topics
  22. Rituximab4▲ 16×4 topics
  23. Prognosis4▲ 7.0×9 topics
  24. Metabolic Syndrome4▲ 2.8×14 topics
  25. Metastasis4▲ 5.9×10 topics
  26. PET Imaging4▲ 12×3 topics
  27. Tumor Microenvironment4▲ 4.5×5 topics
  28. Survival Analysis3▲ 6.8×6 topics
  29. Clinical Guidelines3▲ 6.1×9 topics
  30. Lymphoma3▲ 11×4 topics
  31. Hepatocellular Carcinoma3▲ 8.1×3 topics
  32. Cancer Immunotherapy3▲ 9.6×3 topics
  33. Clinical Outcomes3▲ 6.8×4 topics
  34. Molecular Profiling3▲ 15×3 topics
  35. Surgical Treatment3▲ 7.5×5 topics
  36. Genetic Variants2▲ 8.1×6 topics
  37. Survival2▲ 11×4 topics
  38. Therapeutic Targets2▲ 9.2×5 topics
  39. Gene Expression Profiling2▲ 17×2 topics
  40. Radiofrequency Ablation2▲ 13×2 topics

Which research topics does Azienda Ospedaliero Universitaria Maggiore della Carita publish most on?

By volume in 2022–2025: Amyotrophic Lateral Sclerosis Research, Lymphoma Diagnosis and Treatment, Medical Imaging Techniques and Applications and Chronic Lymphocytic Leukemia Research.

Amyotrophic Lateral Scle…2Amyotrophic Lateral Sclerosis Research: 2 fractional worksLymphoma Diagnosis and T…2Lymphoma Diagnosis and Treatment: 2 fractional worksMedical Imaging Techniques and Applications: 2 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional worksCardiac pacing and defibrillation studies: 2 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksLiver Disease Diagnosis and Treatment: 2 fractional worksHepatocellular Carcinoma…2Hepatocellular Carcinoma Treatment and Prognosis: 2 fractional worksSpine and Intervertebral Disc Pathology: 2 fractional worksAtrial Fibrillation Management and Outcomes: 1 fractional works
NeurologyPathology and Forensic MedicineRadiology, Nuclear Medicine and ImagingGenetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Amyotrophic Lateral Sclerosis Research Neurology 2 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  3. 3 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 2 works
  5. 5 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 2 works
  7. 7 Liver Disease Diagnosis and Treatment Epidemiology 2 works
  8. 8 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 2 works
  9. 9 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 2 works
  10. 10 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.6%not open48.4%

World: 28% of research is openly available.

with international co-authors23.6%domestic only76.4%

World: 19% is written across borders.

How has Azienda Ospedaliero Universitaria Maggiore della Carita's research output changed?

Output in 2018–2022 was 27% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Novara

All research institutions in Novara

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.